Tick-Borne Bacterial Diseases in Europe: Threats to public health

1.

Diuk-Wasser MA, VanAcker MC, Fernandez MP (2021) Impact of land use changes and habitat fragmentation on the eco-epidemiology of tick-borne diseases. J Med Entomol 58(4):1546–1564. https://doi.org/10.1093/jme/tjaa209CrossRefPubMed

2.

de la Fuente J, Estrada-Peña A, Rafael M, Almazán C, Bermúdez S, Abdelbaset AE, Kasaija PD, Kabi F, Akande FA, Ajagbe DO, Bamgbose T, Ghosh S, Palavesam A, Hamid PH, Oskam CL, Egan SL, Duarte-Barbosa A, Hekimoğlu O, Szabó MPJ, Labruna MB, Dahal A (2023) Perception of Ticks and Tick-Borne Diseases Worldwide. Pathogens 12(10):1258. https://doi.org/10.3390/pathogens12101258CrossRefPubMedPubMedCentral

3.

Sykes JE (2023) Tick-Borne Diseases. Vet Clin North Am Small Anim 53(1):141–154. https://doi.org/10.1016/j.cvsm.2022.07.011CrossRef

4.

Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E (2020) Emerging tick-borne diseases. Clin Microbiol Rev 33(2):10–1128. https://doi.org/10.1128/CMR.00083-18CrossRef

5.

Pustijanac E, Buršić M, Talapko J, Škrlec I, Meštrović T, Lišnjić D (2023) Tick-Borne Encephalitis Virus: A Comprehensive Review of Transmission, Pathogenesis, Epidemiology, Clinical Manifestations, Diagnosis, and Prevention. Microorganisms 11(7):1634. https://doi.org/10.3390/microorganisms11071634CrossRefPubMedPubMedCentral

6.

Wolcott KA, Margos G, Fingerle V, Becker NS (2021) Host association of Borrelia burgdorferi sensu lato: A review. Ticks Tick Borne Dis 12(5):101766. https://doi.org/10.1016/j.ttbdis.2021.101766CrossRefPubMed

7.

Strnad M, Hönig V, Růžek D, Grubhoffer L, Rego RO (2017) Europe-wide meta-analysis of Borrelia burgdorferi sensu lato prevalence in questing Ixodes ricinus ticks. Appl Environ Microbiol 83(15):e00609-e617. https://doi.org/10.1128/AEM.00609-17CrossRefPubMedPubMedCentral

8.

Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP (1982) Lyme disease—a tick-borne spirochetosis? Science 216(4552):1317–1319. https://doi.org/10.1126/science.7043737CrossRefPubMed

9.

Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG, Brenner DJ (1984) Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease. Int J Syst Evol 34(4):496–497. https://doi.org/10.1099/00207713-34-4-496CrossRef

10.

Cabello FC, Embers ME, Newman SA, Godfrey HP (2022) Borreliella burgdorferi antimicrobial-tolerant persistence in Lyme disease and posttreatment Lyme disease syndromes. MBio 13(3):e03440-e3521. https://doi.org/10.1128/mbio.03440-21CrossRefPubMedPubMedCentral

11.

Samanta K, Azevedo JF, Nair N, Kundu S, Gomes-Solecki M (2022) Infected Ixodes scapularis Nymphs Maintained in Prolonged Questing under Optimal Environmental Conditions for One Year Can Transmit Borrelia burgdorferi (Borreliella genus novum) to Uninfected Hosts. Microbiol Spectr 10(4):e01377-e1422. https://doi.org/10.1128/spectrum.01377-22CrossRefPubMedPubMedCentral

12.

Steinbrink A, Brugger K, Margos G, Kraiczy P, Klimpel S (2022) The evolving story of Borrelia burgdorferi sensu lato transmission in Europe. Parasitol Res 121(3):781–803. https://doi.org/10.1007/s00436-022-07445-3CrossRefPubMedPubMedCentral

13.

Wodecka B, Kolomiiets V (2023) Genetic Diversity of Borreliaceae Species Detected in Natural Populations of Ixodes ricinus Ticks in Northern Poland. Life 13(4):972. https://doi.org/10.3390/life13040972CrossRefPubMedPubMedCentral

14.

Bengis RG, Leighton FA, Fischer JR, Artois M, Morner T, Tate CM (2004) The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech- Off Int Epizoot. 23(2):497–512

15.

Aguirre AA (2017) Changing patterns of emerging zoonotic diseases in wildlife, domestic animals, and humans linked to biodiversity loss and globalization. ILAR J 58(3):315–318. https://doi.org/10.1093/ilar/ilx035CrossRefPubMed

16.

Stevenson B (2023) The Lyme disease spirochete, Borrelia burgdorferi, as a model vector-borne pathogen: insights on regulation of gene and protein expression. Curr Opin Microbiol 74:102332. https://doi.org/10.1016/j.mib.2023.102332CrossRefPubMed

17.

O’Keeffe KR, Oppler ZJ, Brisson D (2020) Evolutionary ecology of Lyme Borrelia. Infect Genet Evol 85:104570. https://doi.org/10.1016/j.meegid.2020.104570CrossRefPubMedPubMedCentral

18.

Troxell B, Yang XF (2013) Metal-dependent gene regulation in the causative agent of Lyme disease. Front Cell Infect 3:79. https://doi.org/10.3389/fcimb.2013.00079CrossRef

19.

Kahl O, Gray JS (2023) The biology of Ixodes ricinus with emphasis on its ecology. Ticks Tick Borne Dis 14(2):102114. https://doi.org/10.1016/j.ttbdis.2022.102114CrossRefPubMed

20.

Hauck D, Jordan D, Springer A, Schunack B, Pachnicke S, Fingerle V, Strube C (2020) Transovarial transmission of Borrelia spp., Rickettsia spp. and Anaplasma phagocytophilum in Ixodes ricinus under field conditions extrapolated from DNA detection in questing larvae. Parasites Vectors 13:1–11. https://doi.org/10.1186/s13071-020-04049-7CrossRef

21.

Comstedt P, Jakobsson T, Bergström S (2011) Global ecology and epidemiology of Borrelia garinii spirochetes. Infect Ecol Epidemiology 1(1):9545. https://doi.org/10.3402/iee.v1i0.9545CrossRef

22.

Hartfield M, White KJ, Kurtenbach K (2011) The role of deer in facilitating the spatial spread of the pathogen Borrelia burgdorferi. Theor Ecol 4:27–36. https://doi.org/10.1007/s12080-010-0072-2CrossRef

23.

Radolf J, Caimano M, Stevenson B, Hu LT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87–99. https://doi.org/10.1038/nrmicro2714CrossRefPubMedPubMedCentral

24.

Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E (2004) Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72(10):5759–5767. https://doi.org/10.1128/IAI.72.10.5759-5767.2004CrossRefPubMedPubMedCentral

25.

Xu Q, McShan K, Liang FT (2008) Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol Microbiol 69(1):15–29. https://doi.org/10.1111/j.1365-2958.2008.06264.xCrossRefPubMedPubMedCentral

26.

Rizzi J, Nilsen IB, Stagge JH, Gisnås K, Tallaksen LM (2018) Five decades of warming: impacts on snow cover in Norway. Hydrol Res 49(3):670–688. https://doi.org/10.2166/nh.2017.051CrossRef

27.

Hvidsten D, Frafjord K, Gray JS, Henningsson AJ, Jenkins A, Kristiansen BE, Lager M, Rognerud B, Slåtsve AM, Stordal F, Stuen S, Wilhelmsson P (2020) The distribution limit of the common tick, Ixodes ricinus, and some associated pathogens in north-western Europe. Ticks Tick Borne Dis 11(4):101388. https://doi.org/10.1016/j.ttbdis.2020.101388CrossRefPubMed

28.

Burn L, Pilz A, Vyse A, Gutiérrez Rabá AV, Angulo FJ, Tran TMP, Fletcher MA, Gessner BD, Moïsi JC, Stark JH (2023) Seroprevalence of lyme borreliosis in Europe: Results from a systematic literature review (2005–2020). Vector-Borne Zoonotic Dis 23(4):195–220. https://doi.org/10.1089/vbz.2022.0069CrossRefPubMedPubMedCentral

29.

Burn L, Tran TMP, Pilz A, Vyse A, Fletcher MA, Angulo FJ, Gessner BD, Moïsi JC, Jodar L, Stark JH (2023) Incidence of Lyme borreliosis in Europe from National Surveillance Systems (2005–2020). Vector-Borne Zoonotic Dis 23(4):156–171. https://doi.org/10.1089/vbz.2022.0071CrossRefPubMedPubMedCentral

30.

Cerar T, Strle F, Stupica D, Ruzic-Sabljic E, McHugh G, Steere AC, Strle K (2016) Differences in genotype, clinical features, and inflammatory potential of Borrelia burgdorferi sensu stricto strains from Europe and the United States. Emerg Infect Dis 22(5):818. https://doi.org/10.3201/eid2205.151806CrossRefPubMedPubMedCentral

31.

Coburn J, Garcia B, Hu LT, Jewett MW, Kraiczy P, Norris SJ, Skare J (2021) Lyme disease pathogenesis. Curr Issues Mol Biol 42(1):473–518. https://doi.org/10.21775/cimb.042.473CrossRefPubMed

32.

Rudenko N, Golovchenko M, Kybicova K et al (2019) Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters. Parasit Vectors 12(1):237. https://doi.org/10.1186/s13071-019-3495-7CrossRefPubMedPubMedCentral

33.

Yuste RA, Muenkel M, Axarlis K et al (2022) Borrelia burgdorferi modulates the physical forces and immunity signaling in endothelial cells. iScience 25(8):104793. https://doi.org/10.1016/j.isci.2022.104793CrossRefPubMedPubMedCentral

34.

Karvonen K, Nykky J, Marjomäki V, Gilbert L (2021) Distinctive evasion mechanisms to allow persistence of Borrelia burgdorferi in different human cell lines. Front microbiol 12:711291. https://doi.org/10.3389/fmicb.2021.711291CrossRefPubMedPubMedCentral

35.

Strnad M, Rudenko N, Rego RO (2023) Pathogenicity and virulence of Borrelia burgdorferi. Virulence 14(1):2265015. https://doi.org/10.1080/21505594.2023.2265015CrossRefPubMedPubMedCentral

36.

Marques AR, Strle F, Wormser GP (2021) Comparison of Lyme disease in the United States and Europe. Emerg Infect Dis 27(8):2017. https://doi.org/10.3201/eid2708.204763CrossRefPubMedPubMedCentral

37.

Ogrinc K, Lusa L, Lotrič-Furlan S, Bogovič P, Stupica D, Cerar T, Ružić-Sabljić E, Strle F (2016) Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings. Rev Infect Dis 63(3):346–353. https://doi.org/10.1093/cid/ciw299CrossRef

38.

Ogrinc K, Maraspin V, Lusa L, Cerar Kišek T, Ružić-Sabljić E, Strle F (2021) Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. J Intern Med 290(2):335–348. https://doi.org/10.1111/joim.13266CrossRefPubMedPubMedCentral

39.

Stinco G, Ruscio M, Bergamo S, Trotter D, Patrone P (2014) Clinical features of 705 Borrelia burgdorferi seropositive patients in an endemic area of northern Italy. Sci World J 414505. https://doi.org/10.1155/2014/414505

40.

Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O’Connell S, Ornsetin K, Strle F, Gray J (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 17(1):69–79. https://doi.org/10.1111/j.1469-0691.2010.03175.xCrossRefPubMed

41.

Guérin M, Shawky M, Zedan A, Octave S, Avalle B, Maffucci I, Padiolleau-Lefèvre S (2023) Lyme borreliosis diagnosis: State of the art of improvements and innovations. BMC Microbiol 23(1):204. https://doi.org/10.1186/s12866-023-02935-5CrossRefPubMedPubMedCentral

42.

Harris EK, Harton MR, de Mello Marques MA, Belisle JT, Molins CR, Breuner N, Wormser GP, Gilmore RD (2019) Immunoproteomic analysis of Borrelia miyamotoi for the identification of serodiagnostic antigens. Sci Rep 9(1):16808. https://doi.org/10.1038/s41598-019-53248-5CrossRefPubMedPubMedCentral

43.

Arnaboldi PM, Katseff AS, Sambir M, Dattwyler RJ (2022) Linear Peptide Epitopes Derived from ErpP, p35, and FlaB in the Serodiagnosis of Lyme Disease. Pathogens 11(8):944. https://doi.org/10.3390/pathogens11080944CrossRefPubMedPubMedCentral

44.

Koedel U, Fingerle V, Pfister HW (2015) Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol 11(8):446–456. https://doi.org/10.1038/nrneurol.2015.121CrossRefPubMed

45.

Raffetin A, Saunier A, Bouiller K, Caraux-Paz P, Eldin C, Gallien S, Jouenne R, Belkacem A, Salomon J, Patey O, Talagrand-Reboul E, Jaulhac B, Grillon A (2020) Unconventional diagnostic tests for Lyme borreliosis: a systematic review. Clin Microbiol Infect 26(1):51–59. https://doi.org/10.1016/j.cmi.2019.06.033CrossRefPubMed

46.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F (2018) To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect 24(2):118–124. https://doi.org/10.1016/j.cmi.2017.08.025CrossRefPubMed

47.

Stanek G, Strle F (2022) The History, Epidemiology, Clinical Manifestations and Treatment of Lyme Borreliosis. In: Hunfeld KP, Gray J (eds) Lyme Borreliosis. Springer, Cham, pp 77–105. https://doi.org/10.1007/978-3-030-93680-8_4

48.

Bézay N, Hochreiter R, Kadlecek V, Wressnigg N, Larcher-Senn J, Klingler A, Dubischar K, Eder-Lingelbach S, Leroux-Roels I, Leroux-Roels G, Bender W (2023) Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults. Lancet Infect Dis 23(10):1186–1196. https://doi.org/10.1016/S1473-3099(23)00210-4CrossRefPubMed

49.

Wilczek CK, Wenderlein J, Hiereth S, Straubinger RK (2022) A Retrospective Study with a Commercial Vaccine against Lyme Borreliosis in Dogs Using Two Different Vaccination Schedules: Characterization of the Humoral Immune Response. Vaccines 11(1):43. https://doi.org/10.3390/vaccines11010043CrossRefPubMedPubMedCentral

50.

El Karkouri K, Ghigo E, Raoult D, Fournier PE (2022) Genomic evolution and adaptation of arthropod-associated Rickettsia. Sci Rep 12(1):3807. https://doi.org/10.1038/s41598-022-07725-zCrossRefPubMedPubMedCentral

51.

Groß D, Schäfer G (2011) 100th Anniversary of the death of Ricketts: Howard Taylor Ricketts (1871–1910). The namesake of the Rickettsiaceae family. Microbes Infect. 13(1):10–13. https://doi.org/10.1016/j.micinf.2010.09.008CrossRefPubMed

52.

De Vito A, Geremia N, Mameli SM, Fiore V, Serra PA, Rocchitta G, Nuvoli S, Spanu A, Lobrano R, Cossu A, Babudieri S, Madeddu G (2020) Epidemiology, clinical aspects, laboratory diagnosis and treatment of rickettsial diseases in the mediterranean area during COVID-19 pandemic: a review of the literature. Mediterr J Hematol Infect Dis 12(1):e2020056. https://doi.org/10.4084/mjhid.2020.056CrossRefPubMedPubMedCentral

53.

Rovery C, Brouqui P, Raoult D (2008) Questions on Mediterranean spotted fever a century after its discovery. Emerg Infect Dis 14(9):1360. https://doi.org/10.3201/eid1409.071133CrossRefPubMedPubMedCentral

54.

Parola P, Raoult D (2001) Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32(6):897–928. https://doi.org/10.1086/319347CrossRefPubMed

55.

Gould DJ, Miesse ML (1954) Recovery of a rickettsia of the spotted fever group from Microtus pennsylvanicus from Virginia. Proc Soc Exp Biol Med 85(4):558–561. https://doi.org/10.3181/00379727-85-209CrossRefPubMed

56.

Blanton LS (2019) The rickettsioses: a practical update. Infect Dis Clin 33(1):213–229. https://doi.org/10.1016/j.idc.2018.10.010CrossRef

57.

Klein D, Beth-Din A, Cohen R, Lazar S, Glinert I, Zayyad H, Atiya-Nasagi Y (2019) New spotted fever group rickettsia isolate, identified by sequence analysis of conserved genomic regions. Pathogens 9(1):11. https://doi.org/10.3390/pathogens9010011CrossRefPubMedPubMedCentral

58.

Raoult D, Fournier PE, Eremeeva M, Graves S, Kelly PJ, Oteo JA, Sekyeova Z, Tamura A, Tarasevich I, Zhang L (2005) Naming of Rickettsiae and rickettsial diseases. Ann N Y Acad Sci 1063(1):1–12. https://doi.org/10.1196/annals.1355.002CrossRefPubMed

59.

El Karkouri K, Pontarotti P, Raoult D, Fournier PE (2016) Origin and evolution of rickettsial plasmids. PLoS ONE 11(2):e0147492. https://doi.org/10.1371/journal.pone.0147492CrossRefPubMedPubMedCentral

60.

Portillo A, Santibáñez S, García-Álvarez L, Palomar AM, Oteo JA (2015) Rickettsioses in Europe. Microbes Infect 17(11–12):834–838. https://doi.org/10.1016/j.micinf.2015.09.009CrossRefPubMed

61.

Spernovasilis N, Markaki I, Papadakis M, Mazonakis N, Ierodiakonou D (2021) Mediterranean spotted fever: current knowledge and recent advances. Infect Dis Trop Med 6(4):172. https://doi.org/10.3390/tropicalmed6040172CrossRef

62.

Karim S, Kumar D, Budachetri K (2021) Recent advances in understanding tick and rickettsiae interactions. Parasite Immunol 43(5):e12830. https://doi.org/10.1111/pim.12830CrossRefPubMed

63.

Walker DH, Ismail N (2008) Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events. Nat Rev Microbiol 6(5):375–386. https://doi.org/10.1038/nrmicro1866CrossRefPubMed

64.

Reháçek J (1989) Ecological relationships between ticks and rickettsiae. Eur J Epidemiol 5:407–413. https://doi.org/10.1007/BF00140130CrossRefPubMed

65.

Rochlin I, Toledo A (2020) Emerging tick-borne pathogens of public health importance: a mini-review. J Med Microbiol 69(6):781. https://doi.org/10.1099/jmm.0.001206CrossRefPubMedPubMedCentral

66.

Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Peña A, George JC, Golovoljova I, Jaenson TGT, Jensen JK, Jensen PM, Kazimirova M, Oteo JA, Papa A, Pfister K, Plantard O, Randolph SE, Rizzoli A, Santos-Silva MM, Sprong H, Vial L, Hendrickx G, Zeller H, Van Bortel W (2013) Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasite Vectors 6:1–11. https://doi.org/10.1186/1756-3305-6-1CrossRef

67.

Tomassone L, Portillo A, Nováková M, De Sousa R, Oteo JA (2018) Neglected aspects of tick-borne rickettsioses. Parasites Vectors 11:1–11. https://doi.org/10.1186/s13071-018-2856-yCrossRef

68.

Sahni A, Fang R, Sahni SK, Walker DH (2019) Pathogenesis of rickettsial diseases: pathogenic and immune mechanisms of an endotheliotropic infection. Annu. Rev. Pathol.: Mech. Dis 14:127–152. https://doi.org/10.1146/annurev-pathmechdis-012418-012800CrossRef

69.

Chan YGY, Riley SP, Chen E, Martinez JJ (2011) Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B. Infect Immun 79(6):2303–2313. https://doi.org/10.1128/iai.01324-10CrossRefPubMedPubMedCentral

70.

Thepparit C, Bourchookarn A, Petchampai N, Barker SA, Macaluso KR (2010) Interaction of Rickettsia felis with histone H2B facilitates the infection of a tick cell line. J Microbiol 156(Pt9):2855. https://doi.org/10.1099/mic.0.041400-0CrossRef

71.

Sonenshine DE, Macaluso KR (2017) Microbial invasion vs. tick immune regulation. Front Cell Infect Microbiol 7:390. https://doi.org/10.3389/fcimb.2017.00390CrossRefPubMedPubMedCentral

72.

De la Fuente J, Waterhouse RM, Sonenshine DE, Roe RM, Ribeiro JM, Sattelle DB, Hill CA (2016) Tick genome assembled: new opportunities for research on tick-host-pathogen interactions. Front Cell Infect Microbiol 6:103. https://doi.org/10.3389/fcimb.2016.00103CrossRefPubMedPubMedCentral

73.

Socolovschi C, Gaudart J, Bitam I, Huynh TP, Raoult D, Parola P (2012) Why are there so few Rickettsia conorii conorii-infected Rhipicephalus sanguineus ticks in the wild? PLoS Negl Trop Dis 6(6):e1697. https://doi.org/10.1371/journal.pntd.0001697CrossRefPubMedPubMedCentral

74.

Parola P, Socolovschi C, Jeanjean L, Bitam I, Fournier PE, Sotto A, Labauge P, Raoult D (2008) Warmer weather linked to tick attack and emergence of severe rickettsioses. PLoS Negl Trop Dis 2(11):e338. https://doi.org/10.1371/journal.pntd.0000338CrossRefPubMedPubMedCentral

75.

Palomar AM, Santibáñez P, Mazuelas D, Roncero L, Santibáñez S, Portillo A, Oteo JA (2012) Role of birds in dispersal of etiologic agents of tick-borne zoonoses, Spain, 2009. Emerg Infect Dis 18(7):1188. https://doi.org/10.3201/eid1807.111777CrossRefPubMedPubMedCentral

76.

Pascucci I, Di Domenico M, Curini V, Cocco A, Averaimo D, D’Alterio N, Cammà C (2019) Diversity of Rickettsia in ticks collected in Abruzzi and Molise regions (central Italy). Microorganisms 7(12):696. https://doi.org/10.3390/microorganisms7120696CrossRefPubMedPubMedCentral

77.

Ogden NH, Ben Beard C, Ginsberg HS, Tsao JI (2021) Possible effects of climate change on ixodid ticks and the pathogens they transmit: Predictions and observations. J Med Entomol 58(4):1536–1545. https://doi.org/10.1093/jme/tjaa220CrossRefPubMed

78.

Parola P, Paddock CD, Socolovschi C, Labruna MB, Mediannikov O, Kernif AMY, Stenos J, Bitam I, Fournier PE, Raoult D (2013) Update on tick-borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev 26(4):657–702. https://doi.org/10.1128/cmr.00032-13CrossRefPubMedPubMedCentral

79.

Parola P, Paddock CD, Raoult D (2005) Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 18(4):719–756. https://doi.org/10.1128/cmr.00032-13CrossRefPubMedPubMedCentral

80.

Pennisi MG, Caprì A, Solano-Gallego L, Lombardo G, Torina A, Masucci M (2012) Prevalence of antibodies against Rickettsia conorii, Babesia canis, Ehrlichia canis, and Anaplasma phagocytophilum antigens in dogs from the Stretto di Messina area (Italy). Ticks Tick Borne Dis 3(5–6):315–318. https://doi.org/10.1016/j.ttbdis.2012.10.026CrossRefPubMed

81.

Solano-Gallego L, Kidd L, Trotta M, Di Marco M, Caldin M, Furlanello T, Breitschwerdt E (2006) Febrile illness associated with Rickettsia conorii infection in dogs from Sicily. Emerg Infect Dis 12(12):1985. https://doi.org/10.3201/eid1212.060326CrossRefPubMedPubMedCentral

82.

Borawski K, Dunaj J, Pancewicz S, Król M, Czupryna P, Moniuszko-Malinowska A (2019) Tick-borne rickettsioses in Europe–a review. Prz. Epidemiol. 73(4):523–530. https://doi.org/10.32394/pe.73.49CrossRef

83.

Kantsø B, Svendsen CB, Jensen PM, Vennestrøm J, Krogfelt KA (2010) Seasonal and habitat variation in the prevalence of Rickettsia helvetica in Ixodes ricinus ticks from Denmark. Ticks Tick Borne Dis 1(2):101–103. https://doi.org/10.1016/j.ttbdis.2010.01.004CrossRefPubMed

84.

Simser JA, Palmer AT, Fingerle V, Wilske B, Kurtti TJ, Munderloh UG (2002) Rickettsia monacensis sp. nov., a spotted fever group Rickettsia, from ticks (Ixodes ricinus) collected in a European city park. Appl Environ Microbiol 9:4559–4566. https://doi.org/10.1128/AEM.68.9.4559-4566.2002CrossRef

85.

Renvoisé A, Delaunay P, Blanchouin E, Cannavo I, Cua E, Socolovschi C, Parola P, Raoult D (2012) Urban family cluster of spotted fever rickettsiosis linked to Rhipicephalus sanguineus infected with Rickettsia conorii subsp. caspia and Rickettsia massiliae. Ticks Tick Borne Diseas. 3(5–6):389–392. https://doi.org/10.1016/j.ttbdis.2012.10.008CrossRef

86.

Marié JL, Davoust B, Socolovschi C, Raoult D, Parola P (2012) Molecular detection of rickettsial agents in ticks and fleas collected from a European hedgehog (Erinaceus europaeus) in Marseilles. France Comp Immunol Microbiol Infect Dis 35(1):77–79. https://doi.org/10.1016/j.cimid.2011.11.005CrossRefPubMed

87.

Socolovschi C, Reynaud P, Tahar K, Raoult D, Parola P (2012) Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France. Ticks Tick Borne Dis 3(5–6):355–360. https://doi.org/10.1016/j.ttbdis.2012.10.019CrossRefPubMed

88.

Pokrovskiy VI, Ugleva SV, Shabalina SVE, Pokrovsky VI, Pokrovsky VI, Ugleva SV, Shabalina SV (2011) Comparative characteristics of transmissive fevers in the territory of Astrakhan region (clinicoepidemiological evidence). Ter Arkh 83(11):55–59 (https://ter-arkhiv.ru/0040-3660/article/view/30952)

89.

Angelakis E, Pulcini C, Waton J, Imbert P, Socolovschi C, Edouard S, Dellamonica P, Raoult D (2010) Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after tick bite. Clin Infect Dis 50(4):549–551. https://doi.org/10.1086/650172CrossRefPubMed

90.

Guccione C, Rubino R, Colomba C, Anastasia A, Caputo V, Iaria C, Cascio A (2022) Rickettsiosis with Pleural Effusion: A Systematic Review with a Focus on Rickettsiosis in Italy. Trop Med Infect Dis 7(1):11. https://doi.org/10.3390/tropicalmed7010011CrossRefPubMedPubMedCentral

91.

Balážová A, Földvári G, Bilbija B, Nosková E, Široký P (2022) High prevalence and low diversity of Rickettsia in Dermacentor reticulatus ticks. Central Europe Emerg Infect Dis 28(4):893. https://doi.org/10.3201/eid2804.211267CrossRefPubMed

92.

Brouqui P, Parola P, Fournier PE, Raoult D (2007) Spotted fever rickettsioses in southern and eastern Europe. FEMS Microbiol Immunol 49(1):2–12. https://doi.org/10.1111/j.1574-695X.2006.00138.xCrossRef

93.

Duh D, Punda-Polic V, Avsic-Zupanc T, Bouyer D, Walker DH, Popov VL, Jelovsek MG, Trilar T, Bradaric N, Krutti TJ, Strus J (2010) Rickettsia hoogstraalii sp. nov., isolated from hard-and soft-bodied ticks. Int J Syst Evol Microbiol 60(4):977–984. https://doi.org/10.1099/ijs.0.011049-0CrossRefPubMed

94.

Raoult D, Roux V (1997) Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 10(4):694–719. https://doi.org/10.1128/cmr.10.4.694CrossRefPubMedPubMedCentral

95.

Millán J, Proboste T, de Mera IGF, Chirife AD, de la Fuente J, Altet L (2016) Molecular detection of vector-borne pathogens in wild and domestic carnivores and their ticks at the human–wildlife interface. Ticks Tick Borne Dis 7(2):284–290. https://doi.org/10.1016/j.ttbdis.2015.11.003CrossRefPubMed

96.

La Scola B, Raoult D (1997) Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 35(11):2715–2727. https://doi.org/10.1128/jcm.35.11.2715-2727.1997CrossRefPubMedPubMedCentral

97.

Rovery C, Raoult D (2008) Mediterranean spotted fever. Infect Dis Clin N Am 22(3):515–530. https://doi.org/10.1016/j.idc.2008.03.003CrossRef

98.

Demeester R, Claus M, Hildebrand M, Vlieghe E, Bottieau E (2010) Diversity of life-threatening complications due to Mediterranean spotted fever in returning travelers. J Travel Med 17(2):100–104. https://doi.org/10.1111/j.1708-8305.2009.00391.xCrossRefPubMed

99.

Baltadzhiev IG, Popivanova NI (2012) Some epidemiological features of the Mediterranean spotted fever re-emerging in Bulgaria. Folia Med (Plovdiv) 54(1):36–43. https://doi.org/10.2478/v10153-011-0076-8CrossRefPubMed

100.

De Sousa R, França A, Nòbrega SD, Belo A, Amaro M, Abreu T, Pocas J, Proenca P, Vaz J, Torgal J, Bacellar F, Ismail N, Walker DH (2008) Host-and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis 198(4):576–585. https://doi.org/10.1086/590211CrossRefPubMed

101.

Germanakis A, Psaroulaki A, Gikas A, Tselentis Y (2006) Mediterranean spotted fever in Crete, Greece: clinical and therapeutic data of 15 consecutive patients. Ann N Y Acad Sci 1078(1):263–269. https://doi.org/10.1111/j.1469-0691.2009.02910.xCrossRefPubMed

102.

Colomba C, Trizzino M, Giammanco A, Bonura C, Di Bona D, Tolomeo M, Cascio A (2017) Israeli Spotted Fever in Sicily. Description of two cases and minireview. Int J Infect Dis 61:7–12. https://doi.org/10.1128/jcm.43.12.6027-6031.2005CrossRefPubMed

103.

Cohen R, Babushkin F, Shapiro M, Uda M, Atiya-Nasagi Y, Klein D, Finn T (2018) Two cases of Israeli spotted fever with purpura fulminans, Sharon District. Israel Emerg Infect Dis 24(5):835. https://doi.org/10.3201/eid2405.171992CrossRefPubMed

104.

Oteo JA, Portillo A (2012) Tick-borne rickettsioses in Europe. Ticks Tick Borne Dis 3(5–6):271–278. https://doi.org/10.1016/j.ttbdis.2012.10.035CrossRefPubMed

105.

Madeddu G, Mancini F, Caddeo A, Ciervo A, Babudieri S, Maida I, Fiori MA, Rezza G, Mura MS (2012) Rickettsia monacensis as cause of Mediterranean spotted fever–like illness. Italy Emerg Infect Dis 18(4):702. https://doi.org/10.3201/eid1804.111583CrossRefPubMed

106.

Jado I, Oteo JA, Aldámiz M, Gil H, Escudero R, Ibarra V, Portu J, Portillo A, Lezaun MJ, Garcia-Amit C, Rodriguez-Moreno I, Anda P (2007) Rickettsia monacensis and human disease. Spain Emerg Infect Dis 13(9):1405. https://doi.org/10.3201/eid1309.060186CrossRefPubMed

107.

Maleev VV, KhM G, Lazareva EN, Poliakova AM, Astrina OS, Kudriavtsev VA, Arshba TE (2009) Hemostatic disorders and their implication in the pathogenesis of Astrakhan rickettsial fever. Ter Arkh 81(11):32–35PubMed

108.

Torina A, de Mera IGF, Alongi A, Mangold AJ, Blanda V, Scarlata F, Di Marco V, de la Fuente J (2012) Rickettsia conorii Indian tick typhus strain and R. slovaca in humans. Sicily Emerg Infect Dis 18(6):1008. https://doi.org/10.3201/eid1806.110966CrossRefPubMed

109.

Parola P, Rovery C, Rolain JM, Brouqui P, Davoust B, Raoult D (2009) Rickettsia slovaca and R. raoultii in tick-borne rickettsioses. Emerg Infect Dis 15(7):1105. https://doi.org/10.3201/eid1507.081449CrossRefPubMedPubMedCentral

110.

Dubourg G, Socolovschi C, Del Giudice P, Fournier PE, Raoult D (2014) Scalp eschar and neck lymphadenopathy after tick bite: an emerging syndrome with multiple causes. Eur J Clin Microbiol Infect Dis 33:1449–1456. https://doi.org/10.1007/s10096-014-2090-2CrossRefPubMed

111.

Drancourt M, George F, Brouqui P, Sampol J, Raoult D (1992) Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J Infect Dis 166(3):660–663. https://doi.org/10.1093/infdis/166.3.660CrossRefPubMed

112.

Stewart AG, Stewart AG (2021) An update on the laboratory diagnosis of Rickettsia spp. infection. Pathogens 10(10):1319. https://doi.org/10.3390/pathogens10101319CrossRefPubMedPubMedCentral

113.

Bouyer DH, Walker DH (2015) Rickettsia and Orientia. In: Manual of Clinical Microbiology, 11th edition, American Society of Microbiology pp 1122–34.

114.

Paris DH, Dumler JS (2016) State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Curr Opin Infect Dis 29(5):433–439. https://doi.org/10.1097/QCO.0000000000000298CrossRefPubMedPubMedCentral

115.

Bai PSP (2015) Laboratory diagnosis of rickettsial infections. J Pediatr Infect Dis 7(3):85–87. https://doi.org/10.1016/j.pid.2015.12.002CrossRef

116.

Abdad MY, Abou Abdallah R, Fournier PE, Stenos J, Vasoo S (2018) A concise review of the epidemiology and diagnostics of rickettsioses: Rickettsia and Orientia spp. J Clin Microbiol 56(8):10–1128. https://doi.org/10.1128/jcm.01728-17CrossRef

117.

Botelho-Nevers E, Socolovschi C, Raoult D, Parola P (2012) Treatment of Rickettsia spp infections: a review. Expert Rev Anti Infect Ther. 10(12):1425–1437. https://doi.org/10.1586/eri.12.139CrossRefPubMed

118.

Chapman AS (2006) Diagnosis and management of tickborne rickettsial diseases; Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professional. https://stacks.cdc.gov/view/cdc/6709 Accessed 04 December 2023

119.

Colomba C, Saporito L, Polara VF, Rubino R, Titone L (2006) Mediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian children. BMC Infect Dis 6:1–5. https://doi.org/10.1186/1471-2334-6-60CrossRef

120.

Osterloh A (2020) The neglected challenge: Vaccination against rickettsia. PLoS Negl Trop Dis 14(10):e0008704. https://doi.org/10.1371/journal.pntd.0008704CrossRefPubMedPubMedCentral

121.

Rego RO, Trentelman JJ, Anguita J, Nijhof AM, Sprong H, Klempa B, Hajdusek O, Tomas-cortazar J, Azagi T, Strnad M, Knorr S, Sima R, Jalovecka M, Havlikova SA, Lickova M, Slavikova M, Kopacek P, Grubhopper L, Hovius JW (2019) Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission. Parasites Vectors 12(1):1–20. https://doi.org/10.1186/s13071-019-3468-xCrossRef

122.

Celli J, Zahrt TC (2013) Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harb Perspect Med 3(4):a010314. https://doi.org/10.1101/cshperspect.a010314CrossRefPubMedPubMedCentral

123.

Anthony LD, Burke RD, Nano FE (1991) Growth of Francisella spp. in rodent macrophages. Infect Immun. 59(9):3291–3296. https://doi.org/10.1128/iai.59.9.3291-3296.1991CrossRefPubMedPubMedCentral

124.

Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjöstedt A, Edebro H, Forsman M, Byström M, Pelletier M, Wilson CB, Miller SI, Skerrett SJ, Ernst RK (2006) Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun 74(12):6730–6738. https://doi.org/10.1128/iai.00934-06CrossRefPubMedPubMedCentral

125.

Hollis DG, Weaver RE, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ (1989) Francisella philomiragia comb nov (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 27(7):1601–1608. https://doi.org/10.1128/jcm.27.7.1601-1608.1989CrossRefPubMedPubMedCentral

126.

Gürcan S (2014) Epidemiology of tularemia Balkan Med J 31(1):3–10. https://doi.org/10.5152/balkanmedj.2014.13117CrossRefPubMed

127.

McCoy GW, Chapin CW (1912) Further Observations on a Plague-Like Disease of Rodents with a Preliminary Note on the Causative Agent. Bacterium tularense. J. Infect. Dis. 10(1):61–72 (http://www.jstor.org/stable/30071893)CrossRef

128.

McCoy GW, Chapin CW (1912) Bacterium tularense the cause of a plaguelike disease of rodents. Publ Health Bull 53:17–23

129.

Kleim P, Johansson A, Wagner DM (2007) Molecular Epidemiology, Evolution, and Ecology of Francisella. Ann N Y Acad Sci 1101:30–66. https://doi.org/10.1196/annals.1409.011CrossRef

130.

Olusfjev NG, Emelyanova OS, Dunayeva TN (1959) Comparative study of strains of B. tularense in the old and new world and their taxonomy. J Hyg Epidemiol Microbiol Immunol 3(2):138–149

131.

Jellison WL (1961) Tularemia and animal populations: ecology and epizoology. J. Wildl. Dis. 17:1–22 (https://www.jstor.org/stable/41711668)

132.

Dennis DT, Inglesby TV, Henderson DA (2001) Tularemia as a biological weapon: Medical and public health management. J Am Med Assoc 285:2763–2773. https://doi.org/10.1001/jama.285.21.2763CrossRef

133.

Bahuaud O, Le Brun C, Lemaignen A (2021) Host immunity and F. tularensis: a review of tularemia in immunocompromised patients. Microorganisms 9:2539. https://doi.org/10.3390/microorganisms9122539CrossRefPubMedPubMedCentral

134.

Imbimbo C, Karrer U, Wittwer M, Buettcher M (2020) Tularemia in children and adolescents. Pediatr Infect Dis J 39(12):435–438. https://doi.org/10.1097/INF.0000000000002932CrossRef

135.

Ulu-Kilic A, Gulen G, Sezen F et al (2013) Tularemia in Central Anatolia. Infection 41:391–399. https://doi.org/10.1007/s15010-012-0355-1CrossRefPubMed

136.

Sharma R, Patil RD, Singh B, Chakraborty S, Chandran D, Dhama K, Gopinath D, Jairath G, Rialch A, Mal G, Singh P, Chaicumpa W, Saikumar G (2023) Tularemia - a re-emerging disease with growing concern. Vet Q 43(1):1–16. https://doi.org/10.1080/01652176.2023.2277753CrossRefPubMedPubMedCentral

137.

Hopla CE, Hopla AK (1994) Tularemia. In: Beran GW (ed) Handbook of Zoonoses. CRC Press, Boca Raton, FL, pp 113–126

138.

Petersen JM, Mead PS, Schriefer ME (2009) F. tularensis: an arthropod-borne pathogen. Vet Res 40(2):7. https://doi.org/10.1051/vetres:2008045CrossRefPubMed

139.

World Health Organization (WHO) (2007) WHO guidelines on tularaemia. Geneva, Switzerland: World Health Organization. https://stacks.cdc.gov/view/cdc/6943 Accessed 6 December 2023

140.

Dryselius R, Hjertqvist M, Mäkitalo S, Lindblom A, Lilja T, Eklöf D, Lindström (2019) A Large outbreak of tularaemia, central Sweden. July to September Euro Surveill 24:1900603. https://doi.org/10.2807/1560-7917.ES.2019.24.42.1900603CrossRefPubMed

141.

Reese SM, Dietrich G, Dolan MC, Sheldon SW, Piesman J, Petersen JM (2010) Transmission dynamics of Francisella tularensis subspecies and clades by nymphal Dermacentor variabilis (Acari: Ixodidae). Am J Trop Med Hyg. 83(3):645–652. https://doi.org/10.4269/ajtmh.2010.10-0127CrossRefPubMedPubMedCentral

142.

Hopla CE (1974) The ecology of tularemia. Adv Vet Sci Comp Med 18:25–53PubMed

143.

Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, Furie MB (2007) Francisella tularensis Has a Significant Extracellular Phase in Infected Mice. J Infect Dis 196(1):134–137. https://doi.org/10.1086/518611CrossRefPubMed

144.

McCaffrey RL, Allen LA (2006) Pivotal Advance: Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J Leukoc Biol 80:1224–1230. https://doi.org/10.1189/jlb.0406287CrossRefPubMed

145.

Hall JD, Craven RR, Fuller JR, Pickles RJ, Kawula TH (2007) Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation. Infect Immun 75:1034–1039. https://doi.org/10.1128/iai.01254-06CrossRefPubMed

146.

Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76:5843–5852. https://doi.org/10.1128/iai.01176-08CrossRefPubMedPubMedCentral

147.

Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM (2002) Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8(2):225–230. https://doi.org/10.3201/eid0802.010164CrossRefPubMedPubMedCentral

148.

Sjöstedt A (2006) Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect 8:561–567. https://doi.org/10.1016/j.micinf.2005.08.001CrossRefPubMed

149.

Auwaerter PG, Penn RL (2020) Francisella tularensis (Tularemia). In: Bennet JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 9th edn. Elsevier, Philadelphia, p 2759

150.

Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S (1961) Tularemia vaccine study. II Respiratory challenge Arch Intern Med 107:702–714. https://doi.org/10.1001/archinte.1961.03620050068007CrossRefPubMed

151.

Ozanic M, Marecic V, Abu Kwaik Y, Santic M (2015) The divergent intracellular lifestyle of Francisella tularensis in evolutionarily distinct host cells. PLoS Pathog 11(12):e1005208. https://doi.org/10.1371/journal.ppat.1005208CrossRefPubMedPubMedCentral

152.

Yeni DK, Büyük F, Ashraf A, Din Shah MS (2021) Tularemia: a re-emerging tick-borne infectious disease. Folia Microbiol 66:1–14. https://doi.org/10.1007/s12223-020-00827-zCrossRef

153.

Pavlovsky EN (1966) Natural nidality of transmissible diseases with special reference to the Landscape Epidemiology and Zooanthroponoses. IL Univ. Ill, Press, Urbana

154.

Hestvik G, Warns-Petit E, Smith L, Fox N, Uhlhorn H, Artois M, Gavier-Widen D (2015) The status of tularemia in Europe in a one-health context: A review. Epidemiol Infect 143(10):2137–2160. https://doi.org/10.1017/s0950268814002398CrossRefPubMed

155.

Petersen JM, Mead PS (2018) Tularemia. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (eds.) Harrison’s Principles of Internal Medicine, 20e. McGraw Hill Education.

156.

Bush LM (2023) Tularemia (Rabbit Fever; Deer Fly Fever) https://www.msdmanuals.com/home/infections/bacterial-infections-gram-negative-bacteria/tularemia Accessed 05 December 2023

157.

American Veterinary Medical Association website (2003) Tularemia facts. https://www.avma.org/tularemia-facts Accessed 06 December 2023

158.

Centers for Disease Control and Prevention website (2018) https://www.cdc.gov/tularemia/diagnosistreatment/index.html Accessed 04 December 2023

159.

Kelson M, Burnett J, Girgis S, Bakr M (2022) Tularemia: the resurgence of a diagnostic challenge and clinical dilemma in the United States. Cureus 14(7):27363. https://doi.org/10.7759/cureus.27363CrossRef

160.

Versage JL, Severin D, Chu MC, Petersen JM (2003) Development of a multi target real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol 41:5492–5499. https://doi.org/10.1128/jcm.41.12.5492-5499.2003CrossRefPubMedPubMedCentral

161.

Tärnvik A, Chu MC (2007) New Approaches to Diagnosis and Therapy of Tularemia. Ann N Y Acad Sci 1105:378–404. https://doi.org/10.1196/annals.1409.017CrossRefPubMed

162.

Stock KJ (2006) Chapter 22 – Vaccines. In: Ciottone G (ed) Disaster Medicine, 1st Edition, Mosby Inc., pp 145–151. https://doi.org/10.1016/B978-0-323-03253-7.X5001-8

163.

European Centre for Disease Prevention and Control website (2024) Tularemia https://www.ecdc.europa.eu/en/tularaemia Accessed 22 March 2024

164.

Dumler JS, Barbet AF, Bekker CPJ, Dasch GA, Palmer GH, Ray SC, Rikihisa Y, Furangirwa FR (2001) Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 51:2145–2165. https://doi.org/10.1099/00207713-51-6-2145CrossRefPubMed

165.

Kawahara M, Rikihisa Y, Lin Q, Isogai E, Tahara K, Itagaki A, Hiramitsu Y, Tajima T (2006) Novel genetic variants of Anaplasma phagocytophilum, Anaplasma bovis, Anaplasma centrale, and a novel Ehrlichia sp. in wild deer and ticks on two major islands in Japan. Appl Environ Microbiol 72:1102–1109. https://doi.org/10.1128/AEM.72.2.1102-1109.2006CrossRefPubMedPubMedCentral

166.

Rymaszewska A, Grenda S (2008) Bacteria of the genus Anaplasma – characteristics of Anaplasma and their vectors: a review. Vet Med (Praha) 53:573–584. https://doi.org/10.17221/1861-VETMEDCrossRef

167.

Chochlakis D, Ioannou I, Tselentis Y, Psaroulaki A (2010) Human anaplasmosis and Anaplasma ovis variant. Emerg Infect Dis 16:1031–1032. https://doi.org/10.3201/eid1606.090175CrossRefPubMedPubMedCentral

168.

Stuen S, Granquist EG, Silaghi C (2013) Anaplasma phagocytophilum – a widespread multi-host pathogen with highly adaptive strategies. Front Cell Infect Microbiol 3:31. https://doi.org/10.3389/fcimb.2013.00031/fullCrossRefPubMedPubMedCentral

169.

Tate CM, Howerth EW, Mead DG, Dugan VG, Luttrell MP, Sahora Munderloch UG, Davidson WR, Yabsley JM (2013) Anaplasma odocoilei sp. nov. (Family Anaplasmataceae) from white-tailed deer (Odocoileus virginianus). Ticks Tick Bor Dis 4:110–119. https://doi.org/10.1016/j.ttbdis.2012.09.005CrossRef

170.

Bastos AD, Mohammed OB, Bennett NC, Petevinos C, Alagaili AN (2015) Molecular detection of novel Anaplasmataceae closely related to Anaplasma platys and Ehrlichia canis in the dromedary camel (Camelus dromedarius). Vet Microbiol 179:310–314. https://doi.org/10.1016/j.vetmic.2015.06.001CrossRefPubMed

171.

Belkahia H, Said MB, Sayahi L, Alberti A, Messadi L (2015) Detection of novel strains genetically related to Anaplasma platys in Tunisian one-humped camels (Camelus dromedarius). J Infect Dev Ctries 9:1117–1125. https://doi.org/10.3855/jidc.6950CrossRefPubMed

172.

Ehounoud CB, Yao KP, Dahmani M, Achi YL, Amanzougaghene N, N’Douba AK, N’Guessan JD, Raoult D, Fenollar F, Mediannikov O (2016) Multiple pathogens including potential new species in tick vectors in Côte d’Ivoire. PLoS Negl Trop Dis 10:e0004367. https://doi.org/10.1371/journal.pntd.0004367CrossRefPubMedPubMedCentral

173.

Li H, Zheng Y-C, Ma L, Jia N, Jiang B-G, Jiang RR, Huo G-B, Wang YW, Liu HB, Chu YL, Song YD, Yao NN, Sun T, Zen FY, Dumler S, Jiang JF, Cao W-C (2015) Human infection with a novel tick-borne Anaplasma species in China: a surveillance study. Lancet Infect Dis 15:663–670. https://doi.org/10.1016/S1473-3099(15)70051-4CrossRefPubMed

174.

Li Y, Chen Z, Liu Z, Liu J, Yang J, Li Q, Li Y, Lou Y, Yin H (2016) Molecular survey of Anaplasma and Ehrlichia of red deer and sika deer in Gansu, China in 2013. Transbound Emerg Dis 63:228–236. https://doi.org/10.1111/tbed.12335CrossRef

175.

Guo WP, Tian JH, Lin XD, Ni XB, Chen XP, Liao Y, Yang SY, Dumler JS, Holmes EC, Zang YZ (2016) Extensive genetic diversity of Rickettsiales bacteria in multiple mosquito species. Sci. Rep. 6:38770. https://doi.org/10.1038/srep38770CrossRefPubMedPubMedCentral

176.

Dahmani M, Davoust B, Tahir D, Raoult D, Fenollar F, Mediannikov O (2017) Molecular investigation and phylogeny of Anaplasmataceae species infecting domestic animals and ticks in Corsica. France Parasit Vectors 10:302. https://doi.org/10.1186/s13071-017-2233-2CrossRefPubMed

177.

Gordon WS, Brownlee A, Wilson DR, MacLeod J (1932) Tick-borne fever (A hitherto undescribed disease of sheep). J Comp Pathol 45:301–307. https://doi.org/10.1016/S0368-1742(32)80025-1CrossRef

178.

Gordon WS, Brownlee A, Wilson DR (1940) Studies in louping-ill, tick-borne fever and scrapie, in Proceedings: 3d International Congress of Microbiology, New York, NY, USA, 2–9 September 1939; pp 362–363.

179.

Stuen S, Van De Pol I, Bergstrom K, Schouls LM (2020) Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway. J. Clin. Microbiol. 40:3192–3197. https://doi.org/10.1128/jcm.40.9.3192-3197.2002CrossRef

180.

Dehhaghi M, Panahi HKS, Holmes EC, Hudson BJ, Guillemin Gilles J (2019) Human Tick-borne diseases in Australia. Front Cell Infect Microbiol 9:3. https://doi.org/10.3389/fcimb.2019.00003CrossRefPubMedPubMedCentral

181.

Estrada- Peña A, Mihalca AD, Petney TN (2017) Ticks of Europe and North. Africa-A Guide to Species Identification. Springer International Publishing: Cham, Switzerland. https://doi.org/10.1007/978-3-319-63760-0

182.

Chen SM, Dumler JS, Bakken JS, Walker DH (1994) Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 32(3):589–595. https://doi.org/10.1128/jcm.32.3.589-595.1994CrossRefPubMedPubMedCentral

183.

Petrovec M, Lotric Furlan S, Zupanc TA, Strle F, Brouqui P, Roux V, Dumler JS (1997) Human disease in Europe caused by a granulocytic Erlichia species. J Clin Microbiol 35(6):1556–1559. https://doi.org/10.1128/jcm.35.6.1556-1559.1997CrossRefPubMedPubMedCentral

184.

Woldehiwet Z (2010) The natural history of Anaplasma phagocytophilum. Vet Parasitol 167(2–4):108–122. https://doi.org/10.1016/j.vetpar.2009.09.013CrossRefPubMed

185.

McDiarmid A (1965) Modern trends in animal health and husbandry. Some infectious diseases of free-living wild-life. Brit Vet J 121:245–257. https://doi.org/10.1016/S0007-1935(17)41151-1CrossRef

186.

Alberdi MP, Walker AR, Urquhart KA (2000) Field evidence that roe deer (Caprioles carpeolus) are natural host for Ehrlichia phagocytophila. Epidemiol Infect 124:315–323. https://doi.org/10.1017/S0950268899003684CrossRefPubMedPubMedCentral

187.

Stuen S, Engvall EO, Van de Pol I, Schoouls LM (2001) Granulocytic ehrlichiosis in a roe deer calf in Norway. J Wildlife Dis 37:614–616. https://doi.org/10.7589/0090-3558-37.3.614CrossRef

188.

Jenkins A, Handeland K, Stuen S, Schouls L, van de Pol I, Meen R, Kristiansen BE (2001) Ehrlichiosis in a moose calf in Norway. J Wildlife Dis 37:201–203. https://doi.org/10.7589/0090-3558-37.1.201CrossRef

189.

Petrovec M, Bidovec A, Avsic-Zupanc T, Koren S, Sumner JW, Nocholson WL, Childs JE (2000) Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages. Wien Klin Wochenschr 114:641–647

190.

Liz JS, Sumner JW, Pfister K, Brossard M (2002) PCR detection of and serological evidence of granulocytic Ehrlichia; infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra). J Clin Microbiol 40:892–897. https://doi.org/10.1128/jcm.40.3.892-897.2002CrossRefPubMedPubMedCentral

191.

Polin H, Hufnagl P, Haunschmid R, Gruber F, Ladurner G (2004) Molecular evidence of Anaplasma phagocytophilum in Ixodes ricinus ticks and wild animals in Austria. J Clin Microbiol 42:2285–2286. https://doi.org/10.1128/jcm.42.5.2285-2286.2004CrossRefPubMedPubMedCentral

192.

Rojero-Vázquez E, Gordillo-Pérez G, Weber M (2017) Infection of Anaplasma phagocytophilum and Ehrlichia spp. In Opossums and Dogs in Campeche, Mexico: The Role of Tick Infestation. Front Ecol Evol 5:297911. https://doi.org/10.3389/fevo.2017.00161CrossRef

193.

Dumler SJ, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ, Bakken JS (2005) Human granulocytic anaplasmosys and Anaplasma phagocytophyllum. Emerging Infect Dis 11(12):1828–1834. https://doi.org/10.3201/eid1112.050898CrossRef

194.

Ross DE, Levin ML (2004) Effects of Anaplasma phagocytophilum infection on the molting success of Ixodes scapularis (Acari: Ixodidae) larvae. J Med Entomol 41(3):476–483. https://doi.org/10.1603/0022-2585-41.3.476CrossRefPubMed

195.

Dunning Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuolt SV, Eisen J, Seshadri R, Ren Q, Wu M, Utterback T, Smith S, Lewis M, Khouri H, Zhang C, Niu H, Lin Q, Ohashi N, Zhi N, Nelson W, Brinkac LM, Dodson RJ, Rosovitz MJ, Sundaram J, Daugherty SC, Davidsen T, Durkin AS, Gwinnm M, Haft DH, Selengut JD, Sullivan SA, Zafar N, Zhou L, Benahmed F, Forberger H, Halpin R, Mulligan S, Robinson J, White O, Rikihisa Y, Tettelin H (2006) Comparative genomics of emerging human ehrlichiosis agents. PloS Genet 2(2):e21. https://doi.org/10.1371/journal.pgen.0020213CrossRefPubMedPubMedCentral

196.

Sukumaran B, Narasimhan S, Anderson JF, DePonte K, Marc Antonio N, Krishnan MN, Fish D, Telford SR, Cantor FS, Fikrig E (2006) An Ixodes scapularis protein required for survival of Anaplasma phagocytophilum in tick salivary glands. J Exp Med 203:1507–1517. https://doi.org/10.1084/jem.20060208CrossRefPubMedPubMedCentral

197.

Foley J, Nieto N (2007) Anaplasma phagocytophilum subverts tick salivary gland proteins. Trends Parasitol 23:3–5. https://doi.org/10.1016/j.pt.2006.10.003CrossRefPubMed

198.

Atif FA (2015) Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance. Parasitol Res 114:3941–3957. https://doi.org/10.1007/s00436-015-4698-2CrossRefPubMed

199.

Dugat T, Lagree AC, Maillard R, Boulouis HJ, Haddad N (2015) Opening the black box of Anaplasma phagocytophilum diversity: current situation and future perspectives. Front Cell Infect Microbiol 5:61. https://doi.org/10.3389/fcimb.2015.00061CrossRefPubMedPubMedCentral

200.

Jahfari S, Coipan EC, Fonville M, van Leeuwen AD, Hengeveld P, Heylen D, Heyman P, van Maanen C, Butler CM, Földvári G, Szekeres S, van Duijvendijk G, Tack W, Rijks JM, van der Giessen J, Takken W, van Wieren SE, Takumi K, Sprong H (2014) Circulation of four Anaplasma phagocytophilum ecotypes in Europe. Parasit Vectors 7:365. https://doi.org/10.1186/1756-3305-7-365CrossRefPubMedPubMedCentral

201.

Alberti A, Zobba R, Chessa B, Addis MF, Sparagano O, Pinna Parpaglia ML, Cubeddu T, Pintori G, Pittau M (2005) Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States. Appl Environ Microbiol 71:6418–6422. https://doi.org/10.1128/AEM.71.10.6418-6422.2005CrossRefPubMedPubMedCentral

202.

Stigum VM, Jaarsma RI, Sprong H, Rolandsen CM, Mysterud A (2019) Infection prevalence and ecotypes of Anaplasma phagocytophilum in moose Alces alces, red deer Cervus elaphus, roe deer Capreolus capreolus and Ixodes ricinus ticks from Norway. Parasit Vectors 12:1. https://doi.org/10.1186/s13071-018-3256-zCrossRefPubMedPubMedCentral

203.

Rejmanek D, Foley P, Barbet A, Foley J (2012) Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum. Mol Biol Evol 29:391–400. https://doi.org/10.1093/molbev/msr229CrossRefPubMed

204.

Bown KJ, Lambin X, Ogden NH, Petrovec M, Shaw SE, Woldehiwet Z, Birtles RJ (2007) High-resolution genetic fingerprinting of European strains of Anaplasma phagocytophilum by use of multilocus variable-number tandem-repeat analysis. J Clin Microbiol 45:1771–1776. https://doi.org/10.1128/JCM.00365-07CrossRefPubMedPubMedCentral

205.

Wang F, Yan M, Liu A, Chen T, Luo L, Li L, Teng Z, Li B, Ji Z, Jian M, Ding Z, Wen S, Zhang Y, Yue P, Cao W, Xu X, Zhou G, Bao F (2020) The seroprevalence of Anaplasma phagocytophilum in global human populations: A systematic review and meta-analysis. Transbound Emerg Dis 67(5):2050–2064. https://doi.org/10.1111/tbed.13548CrossRefPubMed

206.

Beltrame A, Ruscio M, Arzese A, Rorato G, Negri C, Londero A, Viale P (2006) Human granulocytic anaplasmosis in northeastern Italy. Ann N Y Acad Sci 1078:106–109. https://doi.org/10.1196/annals.1374.015CrossRefPubMed

207.

Jore S, Vanwambeke SO, Viljugrein H, Isaksen K, Kristoffersen AB, Woldehiwet Johansen B, Brun E, Brun-Hansen H, Westermann S, Larsen IL, Ytrehus B, Hofshagen M (2014) Climate and environmental change drives Ixodes ricinus geographical expansion at the northern range margin. Parasit Vectors 7:11. https://doi.org/10.1186/1756-3305-7-11CrossRefPubMedPubMedCentral

208.

Myczka AW, Szewczyk T, Laskowski Z (2022) The Occurrence of Zoonotic Anaplasma phagocytophilum Strains, in the Spleen and Liver of Wild Boars from North-West and Central Parts of Poland. Acta Parasitol 66:1082–1085. https://doi.org/10.1007/s11686-021-00368-6CrossRef

209.

Masuzawa T, Uchishima Y, Fukui T, Okamoto Y, Muto M, Koizumi N, Yamada A (2011) Detection of Anaplasma phagocytophilum from Wild Boars and Deer in Japan. Jpn J Infect Dis 64:333–336. https://doi.org/10.7883/yoken.64.333CrossRefPubMed

210.

Kazimírová M, Hamšíková Z, Špitalská E, Minichová L, Mahríková L, Caban R, Sprong H, Fonville M, Schnittger L, Kocianová E (2018) Diverse tick-borne microorganisms identified in free-living ungulates in Slovakia. Parasit Vectors 11:495. https://doi.org/10.1186/s13071-018-3068-1CrossRefPubMedPubMedCentral

211.

Myczka AW, Kaczor S, Filip-Hutsch K, Czopowicz M, Plis-Kuprianowicz E, Laskowski Z (2022) Prevalence and Genotyping of Anaplasma phagocytophilum Strains from Wild Animals, European Bison (Bison bonasus) and Eurasian Moose (Alces alces) in Poland. Animals 12(9):1222. https://doi.org/10.3390/ani12091222CrossRefPubMedPubMedCentral

212.

Rikihisa Y (2011) Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev 24:469–489. https://doi.org/10.1128/cmr.00064-10CrossRefPubMedPubMedCentral

213.

Bakken JS, Dumler JS (2006) Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci 1078:236–247. https://doi.org/10.1196/annals.1374.042CrossRefPubMed

214.

Ismail N, Bloch KC, McBride JW (2010) Human ehrlichiosis and anaplasmosis. Clin Lab Med 30(1):261–292. https://doi.org/10.1016/j.cll.2009.10.004CrossRefPubMedPubMedCentral

215.

Lotrič-Furlan S, Petrovec M, Avšič-Županc T, Strle F (2003) Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci 990:279–284. https://doi.org/10.1111/j.1749-6632.2003.tb07377.xCrossRefPubMed

216.

Lagler H, Harrison N, Kussmann M, Obermüller M, Burgmann H, Makristathis A, Ramharter M (2017) Direct detection of Anaplasma phagocytophilum by polymerase chain reaction followed by electrospray ionization mass spectrometry from human blood. Int J Infect Dis 60:61–63. https://doi.org/10.1016/j.ijid.2017.05.006CrossRefPubMed

217.

Lotrič-Furlan S, Petrovec M, Zupanc TA, Nicholson WL, Sumner JW, Childs JE, Strle F (1998) Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 27:424–428. https://doi.org/10.1086/514683CrossRefPubMed

218.

Schotthoefer AM, Schrodi SJ, Meece JK, Fritsche TR, Shukla SK (2017) Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis. PLoS ONE 12(6):e0179655. https://doi.org/10.1371/journal.pone.0179655CrossRefPubMedPubMedCentral

219.

Bakken JS, Dumler JS (2015) Human granulocytic anaplasmosis. Infect Dis Clin North Am 29(2):341–355. https://doi.org/10.1016/j.idc.2015.02.007CrossRefPubMedPubMedCentral

220.

Maurin M, Bakken JS, Dumler JS (2003) Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 47(1):413–415. https://doi.org/10.1128/AAC.47.1.413-415.2003CrossRefPubMedPubMedCentral

221.

Collins NE, Liebenberg J, de Villiers EP, Brayton KA, Louw E, Pretorius A, Faber FE, van Heerden H, Josemans A, van Kleef M, Steyn HC, van Strijp MF, Zweygarth E, Jongejan F, Maillard JC, Berthier D, Botha M, Joubert F, Corton CH, Thomson NR, Allsopp MT, Allsopp BA (2005) The genome of the heartwater agent Ehrlichia ruminantium contains multiple tandem repeats of actively variable copy number. Proc Natl Acad Sci USA 102(3):838–843. https://doi.org/10.1073/pnas.0406633102CrossRefPubMedPubMedCentral

222.

Frutos R, Viari A, Ferraz C, Morgat A, Eychenié S, Kandassamy Y, Chantal I, Bensaid A, Coissac E, Vachiery N, Demaille J, Martinez D (2006) Comparative genomic analysis of three strains of Ehrlichia ruminantium reveals an active process of genome size plasticity. J Bacteriol 188(7):2533–2542. https://doi.org/10.1128/JB.188.7.2533-2542.2006CrossRefPubMedPubMedCentral

223.

Walker DH, Dumler JS (1996) Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 2(1):18–29. https://doi.org/10.3201/eid0201.960102CrossRefPubMedPubMedCentral

224.

Esemu SN, Ndip LM, Ndip RN (2011) Ehrlichia species, probable emerging human pathogens in sub-Saharan Africa: environmental exacerbation. Rev Environ Health 26(4):269–279. https://doi.org/10.1515/reveh.2011.034CrossRefPubMed

225.

Walker DH (2005) Ehrlichia under our noses and no one notices. In: Calisher CH, Peters CJ (eds) Infectious diseases from nature: Mechanisms of viral emergence and persistence. Springer Wien, NewYork, pp 147–156CrossRef

226.

Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, Wilson KH, Duntley CW (1991) Isolation and characterization of an Ehrlichia sp from a patient diagnosed with human ehrlichiosis. J Clin Microbiol. 29(12):2741–2745. https://doi.org/10.1128/jcm.29.12.2741-2745.1991CrossRefPubMedPubMedCentral

227.

Anderson BE, Dawson JE, Jones DC, Wilson KH (1991) Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 29(12):2838–2842. https://doi.org/10.1128/jcm.29.12.2838-2842.1991CrossRefPubMedPubMedCentral

228.

Anderson BE, Sumner JW, Dawson JE, Tzianabos T, Greene CR, Olson JG, Fishbein DB, Olsen-Rasmussen M, Holloway BP, George EH et al (1992) Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol 30(4):775–780. https://doi.org/10.1128/jcm.30.4.775-780.1992CrossRefPubMedPubMedCentral

229.

Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y (2006) Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann N Y Acad Sci 1078:110–117. https://doi.org/10.1196/annals.1374.016. (Erratum.In:AnnNYAcadSci.2010Nov;1212(1):130.Xiong,Qingmin[correctedtoXiong,Qingming])CrossRefPubMed

230.

Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, Unver A, Gaudreault-Keener M, Manian FA, Liddell AM, Schmulewitz N, Storch GA (1999) Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 341(3):148–155. https://doi.org/10.1056/NEJM199907153410303CrossRefPubMed

231.

McQuiston JH, Paddock CD, Holman RC, Childs JE (1999) The human ehrlichioses in the United States. Emerg Infect Dis 5(5):635–642. https://doi.org/10.3201/eid0505.990504CrossRefPubMedPubMedCentral

232.

Allsopp MT, Louw M, Meyer EC (2005) Ehrlichia ruminantium: an emerging human pathogen? Ann N Y Acad Sci 1063:358–360. https://doi.org/10.1196/annals.1355.060CrossRefPubMed

233.

Ganguly S, Mukhopadhayay SK (2008) Tick-borne ehrlichiosis infection in human beings. J Vector Borne Dis 45(4):273–280PubMed

234.

Calic SB, Galvão MA, Bacellar F, Rocha CM, Mafra CL, Leite RC, Walker DH (2004) Human ehrlichioses in Brazil: first suspect cases. Braz J Infect Dis 8(3):259–262. https://doi.org/10.1590/s1413-86702004000300011CrossRefPubMed

235.

Kawahara M, Ito T, Suto C, Shibata S, Rikihisa Y, Hata K, Hirai K (1999) Comparison of Ehrlichia muris strains isolated from wild mice and ticks and serologic survey of humans and animals with E. muris as antigen. J Clin Microbiol. 37(4):1123–1129. https://doi.org/10.1128/JCM.37.4.1123-1129.1999CrossRefPubMedPubMedCentral

236.

Smith RP (2005) Tick-Borne Diseases of Humans. Emerg Infect Dis 11:1808–1809. https://doi.org/10.3201/eid1111.051160CrossRefPubMedCentral

237.

Rar V, Golovljova I (2011) Anaplasma, Ehrlichia, and “Candidatus Neoehrlichia” bacteria: pathogenicity, biodiversity, and molecular genetic characteristics, a review. Infect Genet Evol 11(8):1842–1861. https://doi.org/10.1016/j.meegid.2011.09.019CrossRefPubMed

238.

Bjöersdorff A, Bergström S, Massung RF, Haemig PD, Olsen B (2001) Ehrlichia-infected ticks on migrating birds. Emerg Infect Dis 7(5):877–879. https://doi.org/10.3201/eid0705.017517CrossRefPubMedPubMedCentral

239.

Springer YP, Johnson PTJ (2018) Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the United States, 2007–2013. PLoS ONE 13(9):e0204609. https://doi.org/10.1371/journal.pone.0204609CrossRefPubMedPubMedCentral

240.

André MR (2018) Diversity of Anaplasma and Ehrlichia/Neoehrlichia Agents in Terrestrial Wild Carnivores Worldwide: Implications for Human and Domestic Animal Health and Wildlife Conservation. Front Vet Sci 5:293. https://doi.org/10.3389/fvets.2018.00293CrossRefPubMedPubMedCentral

241.

Everett ED, Evans KA, Henry RB, McDonald G (1994) Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann. Intern. Med. 120(9):730–735. https://doi.org/10.7326/0003-4819-120-9-199405010-00002CrossRefPubMed

242.

Ivanova A, Geller J, Katargina O, Värv K, Lundkvist Å, Golovljova I (2017) Detection of Candidatus Neoehrlichia mikurensis and Ehrlichia muris in Estonian ticks. Ticks Tick Borne Dis 8(1):13–17. https://doi.org/10.1016/j.ttbdis.2016.08.010CrossRefPubMed

243.

Arnez M, Luznik-Bufon T, Avsic-Zupanc T, Ruzic-Sabljic E, Petrovec M, Lotric-Furlan S, Strle F (2003) Causes of febrile illnesses after a tick bite in Slovenian children. Pediatr Infect Dis J 22(12):1078–1083. https://doi.org/10.1097/01.inf.0000101477.90756.50CrossRefPubMed

244.

Topolovec J, Puntarić D, Antolović-Pozgain A, Vuković D, Topolovec Z, Milas J, Drusko-Barisić V, Venus M (2003) Serologically detected “new” tick-borne zoonoses in eastern Croatia. Croat Med J 44(5):626–629PubMed

245.

Samardzic S, Marinkovic T, Marinkovic D, Djuricic B, Ristanovic E, Simovic T, Lako B, Vukov B, Bozovic B, Gligic A (2008) Prevalence of antibodies to Rickettsiae in different regions of Serbia. Vector Borne Zoonotic Dis 8(2):219–224. https://doi.org/10.1089/vbz.2007.0122CrossRefPubMed

246.

Arsić B, Gligić A, Ristanović E, Lako B, Potkonjak A, Perunicić M, Pavlović M (2014) A case of human monocytic ehrlichiosis in Serbia. Srp Arh Celok Lek 142(1–2):79–82. https://doi.org/10.2298/sarh1402079aCrossRefPubMed

247.

Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, McQuade JG, Martin CR, Goldsmith CS, Childs JE (1997) Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 35(10):2496–2502. https://doi.org/10.1128/jcm.35.10.2496-2502.1997CrossRefPubMedPubMedCentral

248.

Fishbein DB, Dawson JE, Robinson LE (1994) Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 120(9):736–743. https://doi.org/10.7326/0003-4819-120-9-199405010-00003CrossRefPubMed

249.

Berry DS, Miller RS, Hooke JA, Massung RF, Bennett J, Ottolini MG (1999) Ehrlichial meningitis with cerebrospinal fluid morulae. Pediatr Infect Dis J 18(6):552–525. https://doi.org/10.1097/00006454-199906000-00016CrossRefPubMed

250.

Hulínská D, Kurzová D, Drevová H, Votýpka J (2001) První poznatky o ehrlichióze, prokázané sérologicky a polymerázovou retĕzovou reakcí u pacientů s borreliózou v Ceské republice [First detection of Ehrlichiosis detected serologically and with the polymerase chain reaction in patients with borreliosis in the Czech Republic]. Cas Lek Cesk 140(6):181–184PubMed

251.

Eng TR, Harkess JR, Fishbein DB, Dawson JE, Greene CN, Redus MA, Satalowich FT (1988) Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 264(17):2251–2258. https://doi.org/10.1001/jama.1990.03450170099030CrossRef

252.

Zhang XF, Zhang JZ, Long SW, Ruble RP, Yu XJ (2003) Experimental Ehrlichia chaffeensis infection in beagles. J Med Microbiol 52(11):1021–1026. https://doi.org/10.1099/jmm.0.05234-0CrossRefPubMed

253.

Skotarczak B (2003) Canine ehrlichiosis Ann Agric Environ Med 10(2):137–141PubMed

254.

Anderson BE, Greene CE, Jones DC, Dawson JE (1992) Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis. Int. J. Syst. Bacteriol. 42(2):299–302. https://doi.org/10.1099/00207713-42-2-299CrossRefPubMed

255.

Paddock CD, Folk SM, Shore GM, Machado LJ, Huycke MM, Slater LN, Liddell AM, Buller RS, Storch GA, Monson TP, Rimland D, Sumner JW, Singleton J, Bloch KC, Tang YW, Standaert SM, Childs JE (2001) Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 33(9):1586–1594. https://doi.org/10.1086/323981CrossRefPubMed

256.

Nuti M, Serafini DA, Bassetti D, Ghionni A, Russino F, Rombolà P, Macri G, Lillini E (1998) Ehrlichia infection in Italy. Emerg Infect Dis 4(4):663–665. https://doi.org/10.3201/eid0404.980420CrossRefPubMedPubMedCentral

257.

Smetanová K, Boldis V, Kocianová E, Spitalská E (2007) Detection of Ehrlichia muris in a yellow-necked mouse (Apodemus flavicollis) in Central Slovakia. Acta Virol 51(1):69–71PubMed

258.

Wen B, Rikihisa Y, Mott J, Fuerst PA, Kawahara M, Suto C (1995) Ehrlichia muris sp nov, identified on the basis of 16S rRNA base sequences and serological, morphological, and biological characteristics. Int. J. Syst. Bacteriol. 45(2):250–254. https://doi.org/10.1099/00207713-45-2-250CrossRefPubMed

259.

Yevich SJ, Sánchez JL, DeFraites RF, Rives CC, Dawson JE, Uhaa IJ, Johnson BJ, Fishbein DB (1995) Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 171(5):1266–1273. https://doi.org/10.1093/infdis/171.5.1266CrossRefPubMed

260.

Standaert SM, Yu T, Scott MA, Childs JE, Paddock CD, Nicholson WL, Singleton J Jr, Blaser MJ (2000) Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis 181(3):1082–1088. https://doi.org/10.1086/315346CrossRefPubMed

261.

Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD (1999) Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 37(9):2997–3000. https://doi.org/10.1128/JCM.37.9.2997-3000.1999CrossRefPubMedPubMedCentral

262.

Blevins SM, Greenfield RA, Bronze MS (2008) Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Clevel Clin J Med 75(7):521–530. https://doi.org/10.3949/ccjm.75.7.521CrossRef

263.

Hamilton KS, Standaert SM, Kinney MC (2004) Characteristic peripheral blood findings in human ehrlichiosis. Mod Pathol 17(5):512–517. https://doi.org/10.1038/modpathol.3800075CrossRefPubMed

264.

Chen SM, Cullman LC, Walker DH (1997) Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis. Clin Diagn Lab Immunol 4(6):731–735. https://doi.org/10.1128/cdli.4.6.731-735.1997CrossRefPubMedPubMedCentral

265.

Ijdo JW, Wu C, Magnarelli LA, Stafford KC 3rd, Anderson JF, Fikrig E (2000) Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island. J Clin Microbiol 12:4655–4656. https://doi.org/10.1128/JCM.38.12.4655-4656.2000CrossRef

266.

Kocan AA, Ewing SA, Stallknecht D, Murphy GL, Little S, Whitworth LC, Barker RW (2000) Attempted transmission of Ehrlichia chaffeensis among white-tailed deer by Amblyomma maculatum. J Wildl Dis 36(3):592–594. https://doi.org/10.7589/0090-3558-36.3.592CrossRefPubMed

267.

Ismail N, McBride JW (2017) Tick-Borne Emerging Infections: Ehrlichiosis and Anaplasmosis. Clin Lab Med 37(2):317–340. https://doi.org/10.1016/j.cll.2017.01.006CrossRefPubMed

268.

Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz SM, McElroy KM, McFadden JD, Binnicker MJ, Neitzel DF, Liu G, Nicholson WL, Nelson CM, Franson JJ, Martin SA, Cunningham SA, Steward CR, Bogumill K, Bjorgaard ME, Davis JP, McQuiston JH, Warshauer DM, Wilhelm MP, Patel R, Trivedi VA (2009) Eremeeva ME (2011) Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota. N Engl J Med 365(5):422–429. https://doi.org/10.1056/NEJMoa1010493CrossRef

269.

Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS (2016) Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 65(2):1–44. https://doi.org/10.15585/mmwr.rr6502a1CrossRefPubMed

270.

Branger S, Rolain JM, Raoult D (2004) Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob Agents Chemother 48(12):4822–4828. https://doi.org/10.1128/AAC.48.12.4822-4828.2004CrossRefPubMedPubMedCentral

271.

Morais JD, Dawson JE, Greene C, Filipe AR, Galhardas LC, Bacellar F (1991) First European case of ehrlichiosis. Lancet 338(8767):633–634. https://doi.org/10.1016/0140-6736(91)90644-5CrossRefPubMed

272.

Portillo A, Santibáñez P, Palomar AM, Santibáñez S, Oteo JA (2018) ‘Candidatus Neoehrlichia mikurensis’ in Europe. New Microbes New Infect 22:30–36. https://doi.org/10.1016/j.nmni.2017.12.011CrossRefPubMedPubMedCentral

273.

Grankvist A, Moore ERB, Stadler LS, Pekova S, Bogdan C, Geißdörfer W, Grip-Lindén J, Brandström K, Marsal J, Andréasson K, Lewerin C, Welinder-Olsson C, Wennerås C (2015) Multilocus Sequence Analysis of Clinical “Candidatus Neoehrlichia mikurensis” Strains from Europe. J Clin Microbiol 53(10):3126–3132. https://doi.org/10.1128/jcm.00880-15CrossRefPubMedPubMedCentral

274.

Kawahara M, Rikihisa Y, Isogai E et al (2004) Ultrastructure and phylogenetic analysis of ‘Candidatus Neoehrlichia mikurensis’ in the family Anaplasmataceae, isolated from wild rats and found in Ixodes ovatus ticks. Int J Syst Evol Microbiol 54:1837–1843. https://doi.org/10.1099/ijs.0.63260-0CrossRefPubMed

275.

Glatz M, Müllegger RR, Maurer F, Fingerle V, Achermann Y, Wilske B, Bloemberg GV (2014) Detection of Candidatus Neoehrlichia mikurensis, Borrelia burgdorferi sensu lato genospecies and Anaplasma phagocytophilum in a tick population from Austria. Ticks Tick Borne Dis 5(2):139–144. https://doi.org/10.1016/j.ttbdis.2013.10.006CrossRefPubMed

276.

Wenneras C (2015) Infections with the tick-borne bacterium Candidatus Neoehrlichia mikurensis. Clin Microbiol Infect 21:621–630. https://doi.org/10.1016/j.cmi.2015.02.030CrossRefPubMed

277.

Grankvist A, Andersson PO, Mattsson M et al (2014) Infections with the tick-borne bacterium “Candidatus Neoehrlichia mikurensis” mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clin Infect Dis 58:1716–1722. https://doi.org/10.1093/cid/ciu189CrossRefPubMed

278.

Quarsten H, Henningsson A, Krogfelt KA, Strube C, Wennerås C, Mavin S (2023) Tick-borne diseases under the radar in the North Sea Region. Ticks Tick Borne Dis 14(4):102185. https://doi.org/10.1016/j.ttbdis.2023.102185CrossRefPubMed

279.

Karbowiak G, Biernat B, Stanczak J, Werszko J, Wróblewski P, Szewczyk T, Sytykiewicz H (2016) The role of particular ticks developmental stages in the circulation of tick-borne pathogens in Central Europe. 4. Anaplasmataceae. Ann Parasitol 62(4):267–284. https://doi.org/10.17420/ap6204.62CrossRefPubMed

280.

Movila A, Alekseev AN, Dubinina HV, Toderas I (2013) Detection of tick-borne pathogens in ticks from migratory birds in the Baltic region of Russia. Med Vet Entomol 27(1):113–117. https://doi.org/10.1111/j.1365-2915.2012.01037.xCrossRefPubMed

281.

Obiegala A, Silaghi C (2018) Candidatus Neoehrlichia mikurensis - recent insights and future perspectives on clinical cases, vectors, and reservoirs in Europe. Curr Clin Microbiol Rep 5:1–9. https://doi.org/10.1007/s40588-018-0085-yCrossRef

282.

Obiegala A, Pfeffer M, Pfister K, Tiedemann T, Thiel C, Balling A, Karnath C, Woll D, Silaghi C (2014) Candidatus Neoehrlichia mikurensis and Anaplasma phagocytophilum: prevalences and investigations on a new transmission path in small mammals and ixodid ticks. Parasit Vectors 7:1–10. https://doi.org/10.1186/s13071-014-0563-xCrossRef

283.

Burri C, Schumann O, Schumann C, Gern L (2014) Are Apodemus spp. mice and Myodes glareolus reservoirs for Borrelia miyamotoi, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, R. monacensis and Anaplasma phagocytophilum? Ticks Tick Borne Dis. 5(3):245–251. https://doi.org/10.1016/j.ttbdis.2013.11.007CrossRefPubMed

284.

Tołkacz K, Kowalec M, Alsarraf M, Grzybek M, Dwużnik-Szarek D, Behnke JM, Bajer A (2023) Candidatus Neoehrlichia mikurensis and Hepatozoon sp. in voles (Microtus spp.): occurrence and evidence for vertical transmission. Sci. Rep. 13(1):1733. https://doi.org/10.1038/s41598-023-28346-0CrossRefPubMedPubMedCentral

285.

Ondruš J, Balážová A, Baláž V, Zechmeisterova K, Novobilsky A, Široky P (2020) Candidatus Neoehrlichia mikurensis is widespread in questing Ixodes ricinus ticks in the Czech Republic. Ticks Tick Borne Dis 11(3):101371. https://doi.org/10.1016/j.ttbdis.2020.101371CrossRefPubMed

286.

Welinder-Olsson C, Kjellin E, Vaht K, Jacobsson S, Wennerås C (2010) First case of human “Candidatus Neoehrlichia mikurensis” infection in a febrile patient with chronic lymphocytic leukemia. J Clin Microbiol 48(5):1956–1959. https://doi.org/10.1128/JCM.02423-09CrossRefPubMedPubMedCentral

287.

Pekova S, Vydra J, Kabickova H, Frankova S, Haugvicova R, Mazal O, Cmejla R, Hardekopf DW, Jancuskova T, Kozak T (2011) Candidatus Neoehrlichia mikurensis infection identified in 2 hematooncologic patients: benefit of molecular techniques for rare pathogen detection. Diagn Microbiol Infect Dis 69(3):266–270. https://doi.org/10.1016/j.diagmicrobio.2010.10.004CrossRefPubMed

288.

Fehr JS, Bloemberg GV, Ritter C, Hombach M, Luscher TF, Weber R, Keller PM (2010) Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerg Infect Dis 16(7):1127–1129. https://doi.org/10.3201/eid1607.091907CrossRefPubMedPubMedCentral

289.

Schwieger F, Tebbe CC (1998) A new approach to utilize PCR–singlestrand-conformation polymorphism for 16S rRNA gene-based microbial community analysis. Appl Environ Microbiol 64(12):4870–4876. https://doi.org/10.1128/AEM.64.12.4870-4876.1998CrossRefPubMedPubMedCentral

290.

Jahfari S, Fonville M, Hengeveld P, Reusken C, Scholte EJ, Takken W, Heyman P, Meddlock JM, Heylen D, Kleve J, Sprong H (2012) Prevalence of Neoehrlichia mikurensis in ticks and rodents from North-west Europe. Parasit Vectors 5(1):74–83. https://doi.org/10.1186/1756-3305-5-74CrossRefPubMedPubMedCentral

291.

Diniz PPV, Schulz BS, Hartmann K, Breitschwerdt EB (2011) “Candidatus Neoehrlichia mikurensis” infection in a dog from Germany. J Clin Microbiol 49(5):2059–62. https://doi.org/10.1128/JCM.02327-10CrossRefPubMedPubMedCentral

292.

Hodžić A, Cézanne R, Duscher GG, Harl J, Glawischnig W, Fuehrer HP (2015) Candidatus Neoehrlichia sp. in an Austrian fox is distinct from Candidatus Neoehrlichia mikurensis, but closer related to Candidatus Neoehrlichia lotoris. Parasit. Vectors 8:539. https://doi.org/10.1186/s13071-015-1163-0CrossRefPubMedPubMedCentral

293.

Wass L, Grankvist A, Bell-Sakyi L, Bergström M, Ulfhammer E, Lingblom C, Wennerås C (2019) Cultivation of the causative agent of human neoehrlichiosis from clinical isolates identifies vascular endothelium as a target of infection. Emerg Microbes & Infect. 8(1):413–425. https://doi.org/10.1080/22221751.2019.1584017CrossRef

294.

von Loewenich F, Geissdörfer W, Disqué C, Matten J, Schett G, Sakka SG, Bogdan C (2010) Detection of “Candidatus Neoehrlichia mikurensis” in two patients with severe febrile illnesses: evidence for a European sequence variant. J Clin Microbiol 48:2630–2635. https://doi.org/10.1128/JCM.00588-10CrossRef

295.

Höper L, Skoog E, Stenson M, Grankvist A, Wass L, Olsen B, Nilsson K, Mårtensson A, Söderlind J, Sakinis A, Wennerås C (2021) Vasculitis due to Candidatus Neoehrlichia mikurensis: A Cohort Study of 40 Swedish Patients. Clin Infect Dis 73(7):e2372–e2378. https://doi.org/10.1093/cid/ciaa1217CrossRefPubMed

296.

Venclíková K, Rudolf I, Mendel J, Betasova L, Hubalek Z (2014) Rickettsiae in questing Ixodes ricinus ticks in the Czech Republic. Ticks Tick Borne Dis 5:135–138. https://doi.org/10.1016/j.ttbdis.2013.09.008CrossRefPubMed

297.

Blaňarová L, Stanko M, Miklisová D, Víchová B, Mošanský L, Kraljik J, Bona M, Derdáková M (2016) Presence of Candidatus Neoehrlichia mikurensis and Babesia microti in rodents and two tick species (Ixodes ricinus and Ixodes trianguliceps) in Slovakia. Ticks Tick Borne Dis. 7:319–326. https://doi.org/10.1016/j.ttbdis.2015.11.008CrossRefPubMed

298.

Sawczyn-Domańska A, Zwoliński J, Kloc A, Wójcik-Fatla A (2023) Prevalence of Borrelia, Neoehrlichia mikurensis and Babesia in ticks collected from vegetation in eastern Poland. Exp Appl Acarol 90:409–428. https://doi.org/10.1007/s10493-023-00818-yCrossRefPubMedPubMedCentral

299.

Silaghi C, Woll D, Mahling M, Pfister K, Pfeffer M (2012) Candidatus Neoehrlichia mikurensis in rodents in an area with sympatric existence of the hard ticks Ixodes ricinus and Dermacentor reticulatus. Parasit. Vectors 5:285. https://doi.org/10.1186/1756-3305-5-285CrossRefPubMedPubMedCentral

300.

Derdáková M, Václav R, Pangrácova-Blaňárová L, Selyemová D, Koči J, Walder G, Špitalská E (2014) Candidatus Neoehrlichia mikurensis and its co-circulation with Anaplasma phagocytophilum in Ixodes ricinus ticks across ecologically different habitats of Central Europe. Parasit Vectors 7:160. https://doi.org/10.1186/1756-3305-7-160CrossRefPubMedPubMedCentral

301.

Richter D, Matuschka FR (2012) “Candidatus Neoehrlichia mikurensis”, Anaplasma phagocytophilum, and Lyme disease spirochetes in questing European vector ticks and in feeding ticks removed from people. J. Clin. Microbiol. 50:943–947. https://doi.org/10.1128/JCM.05802-11CrossRefPubMedPubMedCentral

302.

Maurer FP, Keller PM, Beuret C, Joha C, Achermann Y, Gubler J et al (2013) Close geographic association of human neoehrlichiosis and tick populations carrying “Candidatus Neoehrlichia mikurensis” in eastern Switzerland. J Clin Microbiol 51(1):169–176. https://doi.org/10.1128/jcm.01955-12CrossRefPubMedPubMedCentral

303.

Schötta AM, Wijnveld M, Stockinger H, Stanek G (2017) Approaches for reverse line blot-based detection of microbial pathogens in Ixodes ricinus ticks collected in Austria and impact of the chosen method. Appl. Environ. Microbiol. 83(13N):e00489.17. https://doi.org/10.1128/AEM.00489-17CrossRefPubMedPubMedCentral

304.

Silaghi C, Beck R, Oteo JA, Pfeffer M, Sprong H (2016) Neoehrlichiosis: an emerging tick-borne zoonosis caused by Candidatus Neoehrlichia mikurensis. Exp Appl Acarol 68:279–297. https://doi.org/10.1007/s10493-015-9935-yCrossRefPubMed

305.

Sparagano OA (2023) Tick and Tick-Borne Diseases: New Problems Providing New Possible Solutions. Pathogens 12(1):120. https://doi.org/10.3390/pathogens12010120CrossRefPubMedPubMedCentral

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tick-Borne Bacterial Diseases in Europe: Threats to public health

Abstract

Background

Methods and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods and results

Conclusions

Please log in to get access to this content

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials